Clinical trial databases
This article was originally published in The Gray Sheet
Executive SummaryFDA Center for Drug Evaluation and Research issues March 29 guidance for establishing a databank for drug clinical trials as mandated by the FDA Modernization Act. The guidance recommends that trial sponsors submit data in four areas: descriptive information (title, protocol summary, study design/phase/type, condition or disease, intervention); recruitment information (study status, eligibility criteria/gender/age); location and contact information; and administrative data. A Health and Human Services report to Congress last November recommended postponement of such a database for device trials until 2001 so as to accumulate experience with the drug database first (1"The Gray Sheet" Dec. 6, p. 6)
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.